Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Saccharomyces Boulardii wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
2 of 2 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
13 of 15 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Lactoferrin and Saccharomyces Boulardii have evidence — compare verdict strength side-by-side.
200–300 mg daily for adults; 100–200 mg/day for children
30–60 minutes before breakfast, Between meals on an empty stomach
Bovine lactoferrin capsule or powder (≥95% purity)
250-500mg (5-10 billion CFU) daily
With or without food, At least 2 hours away from antifungals
Capsules (lyophilized)
4–8 weeks of use
4–8 weeks
4–8 weeks
6–12 weeks
During use
1-3 days
1-2 weeks
Effect of Lactoferrin Supplementation on Inflammation, Immune Function, and Prevention of Respiratory Tract Infections in Humans: A Systematic Review and Meta-analysis.
Advances in Nutrition (2022) · Meta analysis
Lactoferrin significantly reduced IL-6 in adults (mean difference: -24.9 pg/mL; 95% CI: -41.64, -8.08 pg/mL)
Lactoferrin reduces the risk of respiratory tract infections: A meta-analysis of randomized controlled trials.
Clinical Nutrition ESPEN (2021) · Meta analysis
Pooled analysis of RCTs showed significant reduction in respiratory tract infection risk with lactoferrin supplementation
Comparative Effects between Oral Lactoferrin and Ferrous Sulfate Supplementation on Iron-Deficiency Anemia: A Comprehensive Review and Meta-Analysis of Clinical Trials.
Nutrients (2022) · Meta analysis
Lactoferrin was non-inferior to ferrous sulfate for increasing hemoglobin and serum ferritin
Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis
Frontiers in cellular and infection microbiology (2025) · Meta analysis · n=5036
S. boulardii supplementation in traditional eradication therapy significantly improves the H. pylori eradication rate and reduces the total adverse effects and incidence of diarrhea, bloating, constipation, and nausea.
Probiotics for treating acute infectious diarrhoea
The Cochrane database of systematic reviews (2020) · Meta analysis · n=12127
Effect size was similar in the sensitivity analysis and marked heterogeneity persisted.
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes
Gut microbes (2024) · Meta analysis · n=2871
This review aims to analyze available evidence from human-controlled trials to determine the effect size of probiotic interventions in decolonizing AMR pathogenic bacteria from the gut.
Based on multiple meta-analyses showing OR 0.78 for RTI reduction. Effect more pronounced in children and preterm infants. Conservative estimates due to heterogeneity in populations studied.
Based on multiple meta-analyses showing 1.1-1.6 day reduction in diarrhea duration. Effect size appears to plateau at standard therapeutic doses. Limited data on doses above 20 billion CFU.
AI-estimated from published studies. Interpret as directional guidance.
Saccharomyces Boulardii has a higher evidence score (8.5/10 vs 6.3/10) and wins in 3 of 3 categories.
For support immune system, Lactoferrin has a higher relevance score (92 vs 60).
No known interactions between Lactoferrin and Saccharomyces Boulardii have been documented in our database. However, always consult a healthcare provider before combining supplements.